Ascendant Dx

About:

Ascendant Dx provides disruptive diagnostic technologies to aid in diagnosis and treatment of diseases of women and children.

Website: http://www.ascendantdx.com/

Twitter/X: asn_dx

Top Investors: Arkansas Science & Technology Authority, Arkansas Development Finance Authority

Description:

Ascendant Dx provides develop proteomics-based diagnostic tests. They acquire promising new proteomic research in partnership with leading academic and medical research institutions, and thru clinical research and commercial partnerships, validate and bring these new tests.

Total Funding Amount:

$2M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Springdale, Arkansas, United States

Founded Date:

2010-01-01

Founders:

Anna Daily

Number of Employees:

1-10

Last Funding Date:

2014-05-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai